MARIOTTO S.

The Superconducting Ion Gantry (SIG) project is the contribution from INFN (the Italian National Institute for Nuclear Physics) to the international SIGRUM project with the aim of exploring new technological solutions for the critical elements of a 430 MeV/u carbon ion gantry. The project includes the design and construction of a cos\theta 4 T...

The quest for advancing science and technology continues with the Future Circular Collider (FCC), which requires 16 T bending dipoles to be installed along its 100 km tunnel to achieve a center-of-mass energy of 100 TeV, in its hadron-hadron version. The promising Nb_3Sn technology for superconducting magnets presents a potential solution for...

Objective To describe the clinical and paraclinical findings, treatment options and long-term outcomes in autoimmune encephalitis (AE), with a close look to epilepsy. Methods In this retrospective observational cohort study, we enrolled patients with new-onset seizures in the context of AE. We compared clinical and paraclinical findings in...

The Superconducting Ion Gantry (SIG) project aims to design, construct, and test a curved superconducting dipole demonstrator magnet for an ion gantry (up to a rigidity of 6.6 Tm). The main demonstrator magnet parameters are a dipolar field of 4 T generated into a toroidal aperture with an 80 mm diameter, 1.65 m curvature radius, and 30°...

A new generation of superconducting magnets for applications in ion therapy is under study in the frame of a collaboration between CERN, Centro Nazionale di Adroterapia Oncologica (CNAO), Istituto Nazionale di Fisica Nucleare (INFN) and MedAustron. One of the most critical aspects of these new ion therapy facilities is the optimization of...

Background and purpose Autoimmune encephalitides (AE) include a spectrum of neurological disorders whose diagnosis revolves around the detection of neuronal antibodies (Abs). Consensus-based diagnostic criteria (AE-DC) allow clinic-serological subgrouping of AE, with unclear prognostic implications. The impact of AE-DC on patients' management...